Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
主要な著者: | S. Hatakeyama, T. Yoneyama, Y. Tobisawa, H. Yamamoto, A. Imai, Y. Hashimoto, C. Ohyama |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Elsevier
2020-07-01
|
シリーズ: | European Urology Open Science |
オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2666168320336442 |
類似資料
-
N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
著者:: Hirotake Kodama, 等
出版事項: (2021-02-01) -
Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
著者:: Shingo Hatakeyama, 等
出版事項: (2013-01-01) -
Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
著者:: Itsuto Hamano, 等
出版事項: (2020-07-01) -
Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
著者:: Takuma Narita, 等
出版事項: (2017-04-01) -
Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome
著者:: H. Yamamoto, 等
出版事項: (2020-07-01)